tirzepatide o semaglutide vs. for Weight Loss Comparative safety and side effects

The emerging role of GLP-1 agonists like semaglutide in diabetes and obesity management has led to more and more patients starting their weight loss journey with this science-backed medication

What Science Says Research on glutathione IV therapy is still evolving

As one of the most impactful classes of drugs in recent history, these medications have the potential to dramatically improve the rates of cardiovascular disease in the U.S. Cheng-Han Chen, MD Future research should evaluate the possible mechanisms behind how GLP-1 agonists offer cardiovascular protection beyond their effects on weight loss and blood sugar control, he added.

doi: 10.1111/cen.13003